P10, Inc. — Q1 2022 Form 10-Q
Filing identity: The supplied filing is for P10, Inc. (NYSE: PX), not Ridgepost Capital, Inc. It covers the three months ended March 31, 2022; financial statements are unaudited. Dollar amounts below are in millions unless stated otherwise.
Business context and reporting period
P10 is a private-markets alternative asset manager offering private equity, venture capital, impact investing and private credit solutions. Its revenue is primarily management and advisory fees, often based on committed capital. The 2021 acquisitions of Bonaccord and Hark affect year-over-year comparability; they contributed for the full quarter in 2022 but not in Q1 2021.
Key financial and operating metrics
| Metric | Q1 2022 | Q1 2021 |
|---|---|---|
| Total revenue | $43.3 | $32.8 |
| Operating income | $11.6 | $8.6 |
| Operating margin | 26.8% | 26.1% |
| Net income | $7.8 | $2.7 |
| Net income attributable to P10 | $7.8 | $2.2 |
| Diluted EPS | $0.06 | $0.02 |
| Cash from operating activities | $7.6 | $9.5 |
- Revenue increased 32%; management and advisory fees rose 32% to $43.0 million. Management cited $6.7 million of organic growth at RCP, TrueBridge and Five Points, and $3.8 million from the Hark and Bonaccord acquisitions. Q1 2022 included $0.7 million of catch-up fees.
- Operating expenses rose 31% to $31.7 million. Compensation and benefits increased 55% to $18.5 million, while general, administrative and other expense more than doubled to $4.1 million.
- Net income attributable to P10 increased from $2.2 million to $7.8 million. Lower interest expense helped: net interest expense was $1.4 million versus $5.3 million. The effective tax rate was 25.82%, compared with 22.98%.
- Actual fee-paying assets under management (FPAUM) ended at $17.6 billion, up from $13.1 billion a year earlier. In Q1 2022, $496 million of capital was raised and $224 million deployed, partly offset by $395 million of fee-base stepdowns and expirations. Average fee rates were approximately 1%.
- At March 31, cash and cash equivalents were $23.7 million and restricted cash was $2.0 million. Total assets were $655.5 million; stockholders’ equity was $391.9 million.
- Debt principal was $190.9 million ($65.9 million drawn on the revolver and $125.0 million term loan); balance-sheet debt obligations, net of issuance costs, were $187.7 million. Debt principal fell $25 million during the quarter. The company reported compliance with its minimum-leverage covenant.
Material changes versus the prior comparable period
- Revenue growth reflected both organic fee growth and the full-quarter contribution from Hark and Bonaccord, acquired in September 2021.
- Operating income rose 36%, but higher compensation and administrative costs absorbed much of the revenue increase. Management attributed compensation growth to acquisitions, a $1.7 million one-time Five Points partner-contract buyout, higher stock compensation, public-company compliance staffing and increased headcount.
- Operating cash flow declined 20% to $7.6 million. Changes included a $5.7 million increase in amounts due from related parties, primarily tied to ECG advisory agreements, and a $14.2 million decrease in accrued expenses.
- Cash and cash equivalents declined $17.3 million from year-end, mainly due to the $25 million revolver repayment. Financing activities used $25.0 million, compared with $7.7 million in Q1 2021.
Outlook, risks, contingencies and unusual items
- Outlook: No specific numerical earnings or revenue guidance is provided. Management expects to continue fundraising and grow FPAUM through new investment vehicles and asset-class offerings, and believes operating cash flows, existing cash and financing access can meet liquidity needs.
- Capital returns: After quarter-end, the board declared a $0.03-per-share quarterly dividend, payable June 20, 2022, and authorized a discretionary share-repurchase program of up to $20 million. The program does not require purchases.
- Interest-rate exposure: Borrowings bear interest based on SOFR. P10 estimated that a 100-basis-point rate increase would raise interest expense by approximately $1.4 million over the next 12 months.
- Related-party balances: Due from related parties was $18.9 million, up from $13.1 million at year-end; the filing attributes much of the increase to ECG advisory arrangements. The Enhanced PC advisory-fee receivable was $13.6 million.
- Contingent consideration: The company reported $23.1 million of acquisition-related contingent consideration, all classified as Level 3 fair value. Estimates depend on subjective assumptions and performance targets.
- Stock-option settlement: A $12.5 million liability was recorded in Q1 for a settlement of options; cash payment occurred April 4, 2022. The settlement was a notable cash obligation after quarter-end.
- The company reported no material change to previously disclosed risk factors and did not believe ordinary-course legal matters would result in material losses beyond amounts recognized. Management said disclosure controls were effective and reported no material quarterly change in internal control over financial reporting.
- Management identifies market and fundraising conditions, competition for access to leading fund managers, regulation and tax changes, acquisition financing, and maintaining access to private-market data as business risks.
Important facts for investors to verify
- Confirm the registrant: the filing identifies P10, Inc., rather than Ridgepost Capital, Inc.
- Assess how much of reported revenue and FPAUM growth is organic versus acquisition-related, and monitor fundraising against fee-base stepdowns and expirations.
- Review collection timing and terms for the $18.9 million due from related parties, including the Enhanced PC advisory receivable.
- Track variable-rate debt, covenant headroom, debt maturities (the filing lists $178.4 million of principal in 2025) and cash available after the revolver repayment.
- Evaluate recurring expense levels separately from the one-time partner-contract buyout and stock-option settlement; also assess dilution from outstanding options and awards.
- Consider the assumptions behind contingent consideration and the discretionary nature of the announced dividend and share-repurchase program.